Scientists, librarians and publishers are all affected by the rapidly changing landscape of open access publishing, the proliferation of options available, and in some cases the confusion and uncertainty which can arise. The implementation of Science Europe's "Plan S", which stipulates that from 2021 scientific publications resulting from research funded by public grants must be published in compliant open access journals or platforms, will be a significant milestone. As well as examining the implications of Plan S in the UK and elsewhere, this meeting will explore the broader impact of open access publishing on the chemical sciences, addressing issues such as open access models, organisations' and end-users' experiences, licensing, ethics, benefits and pitfalls. Use cases illustrating new opportunities provided to chemistry by open publishing will also be presented.
Presentations will be delivered over three two-hour sessions:
10 November 13.30 - 15.30
Chair: Dr Ye Li, MIT
Keynote Dr Martin Hicks: Enabling Open Science
Rachel Bruce: Open access for UK Research and Innovation: emerging policy for 2021
Clair Castle: How open are chemists?
11 November 16.00 - 18.00
Chair: Dr Dana Klug, UCL
Dr Marshall Brennan: ChemRxiv: Year One and beyond
Dr Tony Ross-Hellauer: Pros and cons of open peer review
Prof Cameron Neylon: A tale of two societies: Are differences in open access policy driving a split in UK and US chemistry publishing?
12 November 11.00 - 13.00
Chair: David Ball, UKeiG
Helen Malone: The growth in importance of open access sources in the pharmaceutical industry
Dr Egon Willighagen: Open science in an open access world
Dr Neil Hammond: Open Access: a society publisher's perspective
Registration
This event will be free to attend, but registration is required.
This meeting is part of a five-day series exploring the theme of open chemical science. Further information about the series can be found at the link on this page.
Presentations will be delivered over three two-hour sessions:
10 November 13.30 - 15.30
Chair: Dr Ye Li, MIT
Keynote Dr Martin Hicks: Enabling Open Science
Rachel Bruce: Open access for UK Research and Innovation: emerging policy for 2021
Clair Castle: How open are chemists?
11 November 16.00 - 18.00
Chair: Dr Dana Klug, UCL
Dr Marshall Brennan: ChemRxiv: Year One and beyond
Dr Tony Ross-Hellauer: Pros and cons of open peer review
Prof Cameron Neylon: A tale of two societies: Are differences in open access policy driving a split in UK and US chemistry publishing?
12 November 11.00 - 13.00
Chair: David Ball, UKeiG
Helen Malone: The growth in importance of open access sources in the pharmaceutical industry
Dr Egon Willighagen: Open science in an open access world
Dr Neil Hammond: Open Access: a society publisher's perspective
Registration
This event will be free to attend, but registration is required.
This meeting is part of a five-day series exploring the theme of open chemical science. Further information about the series can be found at the link on this page.
